• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于癌症治疗的细菌药物递送系统:“为何”与“如何”

Bacterial Drug Delivery Systems for Cancer Therapy: "Why" and "How".

作者信息

Zhao Xiangcheng, Xie Nuli, Zhang Hailong, Zhou Wenhu, Ding Jinsong

机构信息

Xiangya School of Pharmaceutical Science, Central South University, Changsha 410006, China.

Changsha Jingyi Pharmaceutical Technology Co., Ltd., Changsha 410006, China.

出版信息

Pharmaceutics. 2023 Aug 27;15(9):2214. doi: 10.3390/pharmaceutics15092214.

DOI:10.3390/pharmaceutics15092214
PMID:37765183
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10534357/
Abstract

Cancer is one of the major diseases that endanger human health. However, the use of anticancer drugs is accompanied by a series of side effects. Suitable drug delivery systems can reduce the toxic side effects of drugs and enhance the bioavailability of drugs, among which targeted drug delivery systems are the main development direction of anticancer drug delivery systems. Bacteria is a novel drug delivery system that has shown great potential in cancer therapy because of its tumor-targeting, oncolytic, and immunomodulatory properties. In this review, we systematically describe the reasons why bacteria are suitable carriers of anticancer drugs and the mechanisms by which these advantages arise. Secondly, we outline strategies on how to load drugs onto bacterial carriers. These drug-loading strategies include surface modification and internal modification of bacteria. We focus on the drug-loading strategy because appropriate strategies play a key role in ensuring the stability of the delivery system and improving drug efficacy. Lastly, we also describe the current state of bacterial clinical trials and discuss current challenges. This review summarizes the advantages and various drug-loading strategies of bacteria for cancer therapy and will contribute to the development of bacterial drug delivery systems.

摘要

癌症是危害人类健康的主要疾病之一。然而,抗癌药物的使用伴随着一系列副作用。合适的药物递送系统可以降低药物的毒副作用并提高药物的生物利用度,其中靶向药物递送系统是抗癌药物递送系统的主要发展方向。细菌是一种新型药物递送系统,因其具有肿瘤靶向性、溶瘤性和免疫调节特性,在癌症治疗中显示出巨大潜力。在这篇综述中,我们系统地描述了细菌为何是抗癌药物的合适载体以及这些优势产生的机制。其次,我们概述了如何将药物加载到细菌载体上的策略。这些载药策略包括细菌的表面修饰和内部修饰。我们重点关注载药策略,因为合适的策略在确保递送系统的稳定性和提高药物疗效方面起着关键作用。最后,我们还描述了细菌临床试验的现状并讨论了当前面临的挑战。这篇综述总结了细菌用于癌症治疗的优势和各种载药策略,将有助于细菌药物递送系统的发展。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/045f/10534357/ec0573b88207/pharmaceutics-15-02214-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/045f/10534357/146a989d93e7/pharmaceutics-15-02214-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/045f/10534357/bb0e336989bc/pharmaceutics-15-02214-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/045f/10534357/c3c90ea896f9/pharmaceutics-15-02214-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/045f/10534357/e7f5db616fce/pharmaceutics-15-02214-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/045f/10534357/ec0573b88207/pharmaceutics-15-02214-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/045f/10534357/146a989d93e7/pharmaceutics-15-02214-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/045f/10534357/bb0e336989bc/pharmaceutics-15-02214-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/045f/10534357/c3c90ea896f9/pharmaceutics-15-02214-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/045f/10534357/e7f5db616fce/pharmaceutics-15-02214-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/045f/10534357/ec0573b88207/pharmaceutics-15-02214-g003.jpg

相似文献

1
Bacterial Drug Delivery Systems for Cancer Therapy: "Why" and "How".用于癌症治疗的细菌药物递送系统:“为何”与“如何”
Pharmaceutics. 2023 Aug 27;15(9):2214. doi: 10.3390/pharmaceutics15092214.
2
Genetically engineered oncolytic bacteria as drug delivery systems for targeted cancer theranostics.基因工程改造的溶瘤细菌作为用于靶向癌症诊疗的药物递送系统。
Acta Biomater. 2021 Apr 1;124:72-87. doi: 10.1016/j.actbio.2021.02.006. Epub 2021 Feb 6.
3
Decorated bacteria and the application in drug delivery.经修饰的细菌及其在药物传递中的应用。
Adv Drug Deliv Rev. 2022 Sep;188:114443. doi: 10.1016/j.addr.2022.114443. Epub 2022 Jul 9.
4
Bacteria and bacterial derivatives as drug carriers for cancer therapy.细菌和细菌衍生物作为癌症治疗的药物载体。
J Control Release. 2020 Oct 10;326:396-407. doi: 10.1016/j.jconrel.2020.07.009. Epub 2020 Jul 16.
5
Bacterial ghosts as a novel advanced targeting system for drug and DNA delivery.细菌幽灵作为一种新型的药物和DNA递送先进靶向系统。
Expert Opin Drug Deliv. 2006 Jan;3(1):11-22. doi: 10.1517/17425247.3.1.11.
6
[Development of antituberculous drugs: current status and future prospects].[抗结核药物的研发:现状与未来前景]
Kekkaku. 2006 Dec;81(12):753-74.
7
Membrane Derived Vesicles as Biomimetic Carriers for Targeted Drug Delivery System.膜衍生囊泡作为仿生载体用于靶向药物传递系统。
Curr Top Med Chem. 2020;20(27):2472-2492. doi: 10.2174/1568026620666200922113054.
8
Advances in bacteria-based drug delivery systems for anti-tumor therapy.基于细菌的抗肿瘤治疗药物递送系统的研究进展。
Clin Transl Immunology. 2024 Jun 26;13(7):e1518. doi: 10.1002/cti2.1518. eCollection 2024.
9
Nanogels as target drug delivery systems in cancer therapy: A review of the last decade.纳米凝胶作为癌症治疗中的靶向给药系统:过去十年综述
Front Pharmacol. 2022 Sep 8;13:874510. doi: 10.3389/fphar.2022.874510. eCollection 2022.
10
Combination of drugs and carriers in drug delivery technology and its development.药物递送技术中药物与载体的组合及其发展。
Drug Des Devel Ther. 2019 Apr 30;13:1401-1408. doi: 10.2147/DDDT.S198056. eCollection 2019.

引用本文的文献

1
The ladder of regulatory stringency and balance: an application to the US FDA's regulation of bacterial live therapeutics.监管严格性与平衡性的阶梯:应用于美国食品药品监督管理局对细菌活菌疗法的监管
Gut Microbes. 2025 Dec;17(1):2517377. doi: 10.1080/19490976.2025.2517377. Epub 2025 Jun 12.
2
Transforming bacterial pathogens into wonder tools in cancer immunotherapy.将细菌病原体转化为癌症免疫治疗中的神奇工具。
Mol Ther. 2025 Mar 5;33(3):866-882. doi: 10.1016/j.ymthe.2025.01.029. Epub 2025 Jan 17.
3
Impact on Human Health of spp. and Their Lipopolysaccharides: Possible Therapeutic Role and Asymptomatic Presence Consequences.

本文引用的文献

1
Phase I Study of SYNB1891, an Engineered E. coli Nissle Strain Expressing STING Agonist, with and without Atezolizumab in Advanced Malignancies.SYNB1891 是一株经基因工程改造的表达 STING 激动剂的大肠杆菌 Nissle 株,联合或不联合阿替利珠单抗治疗晚期恶性肿瘤的 I 期研究。
Clin Cancer Res. 2023 Jul 5;29(13):2435-2444. doi: 10.1158/1078-0432.CCR-23-0118.
2
Dressing Bacteria With a Hybrid Immunoactive Nanosurface to Elicit Dual Anticancer and Antiviral Immunity.用混合免疫活性纳米表面修饰细菌以引发双重抗癌和抗病毒免疫。
Adv Mater. 2023 Mar;35(11):e2210949. doi: 10.1002/adma.202210949. Epub 2023 Feb 5.
3
IFN-γ enhances the antitumor activity of attenuated -mediated cancer immunotherapy by increasing M1 macrophage and CD4 and CD8 T cell counts and decreasing neutrophil counts.
spp.及其脂多糖对人类健康的影响:可能的治疗作用和无症状存在的后果。
Int J Mol Sci. 2024 Nov 5;25(22):11868. doi: 10.3390/ijms252211868.
4
Bacterial derivatives mediated drug delivery in cancer therapy: a new generation strategy.细菌衍生物介导的药物传递在癌症治疗中的应用:新一代策略。
J Nanobiotechnology. 2024 Aug 24;22(1):510. doi: 10.1186/s12951-024-02786-w.
5
Repolarizing neutrophils via MnO nanoparticle-activated STING pathway enhances Salmonella-mediated tumor immunotherapy.通过 MnO 纳米颗粒激活 STING 通路使中性粒细胞再极化增强沙门氏菌介导的肿瘤免疫治疗。
J Nanobiotechnology. 2024 Jul 27;22(1):443. doi: 10.1186/s12951-024-02726-8.
6
Long-Term Tumor-Targeting Effect of as a Drug Delivery System.作为一种药物递送系统的长期肿瘤靶向作用。
Pharmaceuticals (Basel). 2024 Mar 26;17(4):421. doi: 10.3390/ph17040421.
7
Bacteria-Based Nanoprobes for Cancer Therapy.基于细菌的纳米探针用于癌症治疗。
Int J Nanomedicine. 2024 Jan 23;19:759-785. doi: 10.2147/IJN.S438164. eCollection 2024.
干扰素-γ通过增加M1巨噬细胞、CD4和CD8 T细胞数量并减少中性粒细胞数量,增强减毒介导的癌症免疫疗法的抗肿瘤活性。
Front Bioeng Biotechnol. 2022 Sep 29;10:996055. doi: 10.3389/fbioe.2022.996055. eCollection 2022.
4
Bacteriolytic therapy with Clostridium ghonii for experimental solid tumors.利用腐败梭菌(Clostridium ghonii)治疗实验性实体瘤的溶菌疗法。
Biochem Biophys Res Commun. 2022 Dec 17;634:114-121. doi: 10.1016/j.bbrc.2022.09.106. Epub 2022 Oct 2.
5
Freeze-drying: A flourishing strategy to fabricate stable pharmaceutical and biological products.冷冻干燥:一种制造稳定药物和生物制品的热门策略。
Int J Pharm. 2022 Nov 25;628:122233. doi: 10.1016/j.ijpharm.2022.122233. Epub 2022 Sep 30.
6
Bacteria loaded with glucose polymer and photosensitive ICG silicon-nanoparticles for glioblastoma photothermal immunotherapy.负载葡萄糖聚合物和光敏 ICG 硅纳米颗粒的细菌用于胶质母细胞瘤光热免疫治疗。
Nat Commun. 2022 Sep 1;13(1):5127. doi: 10.1038/s41467-022-32837-5.
7
Tumor-associated neutrophils and neutrophil-targeted cancer therapies.肿瘤相关中性粒细胞与针对中性粒细胞的癌症治疗
Biochim Biophys Acta Rev Cancer. 2022 Sep;1877(5):188762. doi: 10.1016/j.bbcan.2022.188762. Epub 2022 Jul 16.
8
Decorated bacteria and the application in drug delivery.经修饰的细菌及其在药物传递中的应用。
Adv Drug Deliv Rev. 2022 Sep;188:114443. doi: 10.1016/j.addr.2022.114443. Epub 2022 Jul 9.
9
Therapeutic Applications of Magnetotactic Bacteria and Magnetosomes: A Review Emphasizing on the Cancer Treatment.趋磁细菌和磁小体的治疗应用:一篇侧重于癌症治疗的综述
Front Bioeng Biotechnol. 2022 Apr 25;10:789016. doi: 10.3389/fbioe.2022.789016. eCollection 2022.
10
Intravenous Delivery of Living Elicits Gasdmermin-Dependent Tumor Pyroptosis and Motivates Anti-Tumor Immune Response.活细胞的静脉内递送引发Gasdermin-D依赖性肿瘤细胞焦亡并激发抗肿瘤免疫反应。
ACS Nano. 2022 Mar 22;16(3):4102-4115. doi: 10.1021/acsnano.1c09818. Epub 2022 Mar 9.